Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma

por Vitale, Maria Giuseppa, Maruzzo, Marco, Sabbatini, Roberto
Publicado 2023

Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline

por Maruzzo, Marco, Brunello, Antonella, Diminutto, Alberto, Rastrelli, Marco, Basso, Umberto
Publicado 2016

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma

por Gatto, Francesco, Maruzzo, Marco, Magro, Cristina, Basso, Umberto, Nielsen, Jens
Publicado 2016

Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases

por Zanardi, Elisa, Maruzzo, Marco, Montesco, Maria C., Roma, Anna, Rastrelli, Marco, Basso, Umberto
Publicado 2014

Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa)

por Bergamo, Francesca, Maruzzo, Marco, Basso, Umberto, Montesco, Maria Cristina, Zagonel, Vittorina, Gringeri, Enrico, Cillo, Umberto
Publicado 2014

Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review

por Pierantoni, Francesco, Maruzzo, Marco, Brunello, Antonella, Chiusole, Benedetta, Pusole, Grazia, Bezzon, Elisabetta, Basso, Umberto, Zagonel, Vittorina
Publicado 2019

Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience

por Maruzzo, Marco, Martin-Liberal, Juan, Messiou, Christina, Miah, Aisha, Thway, Khin, Alvarado, Rolyn, Judson, Ian, Benson, Charlotte
Publicado 2015

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical...

por Sharova, Evgeniya, Maruzzo, Marco, Del Bianco, Paola, Cavallari, Ilaria, Pierantoni, Francesco, Basso, Umberto, Ciminale, Vincenzo, Zagonel, Vittorina
Publicado 2021

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience

por Bimbatti, Davide, Dionese, Michele, Lai, Eleonora, Cavasin, Nicolò, Basso, Umberto, Mattana, Alvise, Pierantoni, Francesco, Zagonel, Vittorina, Maruzzo, Marco
Publicado 2022

Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience

por Bimbatti, Davide, Pierantoni, Francesco, Lai, Eleonora, Ballestrin, Melissa, Cavasin, Nicolò, Erbetta, Elisa, De Toni, Chiara, Basso, Umberto, Maruzzo, Marco
Publicado 2023

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy

por Dionese, Michele, Basso, Umberto, Pierantoni, Francesco, Lai, Eleonora, Cavasin, Nicolò, Erbetta, Elisa, Jubran, Salim, Bonomi, Giorgio, Bimbatti, Davide, Maruzzo, Marco
Publicado 2023

Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial

por Bimbatti, Davide, Lai, Eleonora, Pierantoni, Francesco, Maruzzo, Marco, Msaki, Aichi, De Toni, Chiara, Dionese, Michele, Feltrin, Alessandra, Basso, Umberto, Zagonel, Vittorina
Publicado 2022

Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

por Rossi, Ernesto, Bersanelli, Melissa, Gelibter, Alain Jonathan, Borsellino, Nicolò, Caserta, Claudia, Doni, Laura, Maruzzo, Marco, Mosca, Alessandra, Pisano, Carmela, Verzoni, Elena, Zucali, Paolo Andrea
Publicado 2021

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience

por Brunello, Antonella, Rizzato, Mario Domenico, Rastrelli, Marco, Roma, Anna, Maruzzo, Marco, Basso, Umberto, Fiduccia, Pasquale, Buzzaccarini, Maria Samaritana, Scarzello, Giovanni, Rossi, Carlo Riccardo, Zagonel, Vittorina
Publicado 2015

Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators

por Stellato, Marco, Procopio, Giuseppe, De Giorgi, Ugo, Maruzzo, Marco, Bimbatti, Davide, Mennitto, Alessia, Sbrana, Andrea, Roviello, Giandomenico, Casadei, Chiara, Sepe, Pierangela, Pignata, Sandro, Santini, Daniele
Publicado 2021

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma

por Catalano, Martina, De Giorgi, Ugo, Maruzzo, Marco, Bimbatti, Davide, Buti, Sebastiano, Mazzaschi, Giulia, Procopio, Giuseppe, Santoni, Matteo, Galli, Luca, Conca, Raffaele, Doni, Laura, Antonuzzo, Lorenzo, Roviello, Giandomenico
Publicado 2022

Renal cell carcinoma: the population, real world, and cost-of-illness

por Buja, Alessandra, De Luca, Giuseppe, Gatti, Maura, Cozzolino, Claudia, Rugge, Massimo, Zorzi, Manuel, Gardi, Mario, Sepulcri, Matteo, Bimbatti, Davide, Baldo, Vincenzo, Maruzzo, Marco, Basso, Umberto, Zagonel, Vittorina
Publicado 2022

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy

por Verzoni, Elena, Pappagallo, Giovanni, Alongi, Filippo, Arcangeli, Stefano, Francolini, Giulio, Galanti, Daniele, Galli, Luca, Maruzzo, Marco, Rossetti, Sabrina, Siepe, Giambattista, Triggiani, Luca, Zucali, Paolo Andrea, D’Angelillo, Rolando Maria
Publicado 2022

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)

por Maruzzo, Marco, Verzoni, Elena, Vitale, Maria Giuseppa, Dionese, Michele, Buti, Sebastiano, Galli, Luca, Zivi, Andrea, Watutantrige-Fernando, Sara, Zielli, Teresa, Zanardi, Elisa, Sabbatini, Roberto, Basso, Umberto, Zagonel, Vittorina, Procopio, Giuseppe
Publicado 2021

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program

por Kollàr, Attila, Maruzzo, Marco, Messiou, Christina, Cartwright, Elisabeth, Miah, Aisha, Martin-Liberal, Juan, Thway, Khin, McGrath, Ellen, Dunlop, Alison, Khabra, Komel, Seddon, Beatrice, Dileo, Palma, Linch, Mark, Judson, Ian, Benson, Charlotte
Publicado 2014